Neuroendocrine Neoplasms of the Urinary Bladder: Integrating Molecular Advances into a Refined Classification System
A refined, bladder-specific framework that incorporates proliferative indices, molecular alterations, and recognition of mixed neuroendocrine–non-neuroendocrine neoplasms is proposed, with the goal of improving diagnostic reproducibility and informing future biomarker-driven therapeutic strategies.